Copyright
©The Author(s) 2015.
World J Respirol. Jul 28, 2015; 5(2): 102-111
Published online Jul 28, 2015. doi: 10.5320/wjr.v5.i2.102
Published online Jul 28, 2015. doi: 10.5320/wjr.v5.i2.102
Table 7 Phase II study of single-agent erlotinib in the treatment of advanced non-small-cell lung cancer elderly patients
| Ref. | Previous chemotherapy | Age (yr) | No. of patients | RR (%) | SD (%) | MST (mo) | Toxicity G ≥ 3 |
| Jackman et al[67] | No (100%) | ≥ 70 | 58 | 6 (10.9) | 30 (54.5) | 10.5 | G ≥ 3 toxicity 30% |
- Citation: Buffoni L, Consito L, Filippi AR, Ruffini E, Solidoro P, Bironzo P, Satolli MA, Schena M, Ciuffreda L. Advanced non-small cell lung cancer in elderly patients: A review. World J Respirol 2015; 5(2): 102-111
- URL: https://www.wjgnet.com/2218-6255/full/v5/i2/102.htm
- DOI: https://dx.doi.org/10.5320/wjr.v5.i2.102